Unless a specific protocol explicitly calls for saline, stick with bacteriostatic water
"Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act, Category 2 substances." FDA Docket 2022
Each batch of AOD9604 5mg is manufactured according to research-grade production standards and undergoes comprehensive analytical verification before release
VEGF-stimulating compounds can, in principle, support the vascularization of existing tumors or accelerate the growth of pre-malignant lesions
However, during this multiplication, some of the cells become senescent (become senescent) and impede healing instead of promoting it
Potential concerns include unknown long-term safety, product quality variability, and theoretical risks related to angiogenesis and tumor growth